12:00 AM
 | 
Aug 17, 2009
 |  BC Week In Review  |  Company News  |  Deals

Clinical Data, CombinatoRx deal

Clinical Data's PGxHealth division granted CombinatoRx exclusive, worldwide rights to ATL313 for use to treat multiple myeloma (MM) and other B cell malignancies in combination with standard of care chemotherapy, such as Velcade bortezomib from ...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >